UK: MHRA Letter on CBD Creates Both Clarity and Confusion
In October, the MHRA announced its plans to regulate CBD containing products as medicines. have been following the story as the situation has developed and more information has been made available. Yesterday Drugscience published a letter by the MHRA responding to questions asked by Prof David Nutt, founder of Drugscience, about the regulation of CBD.
The MHRA letter published yesterday in response to questions from Drugscience is unfortunately both helpful and confusing. While it provides clarification on some key questions regarding the MHRA opinion on Cannabidiol’s medical classification, at the same time the path forward following the 31st December deadline remains somewhat vague.
Although taken aback initially, I have been a supporter of the MHRA decision. While it may feel that the authorities are taking away a natural, plant-based therapeutically beneficial product that we should all be entitled to have access to, we must recognise that one...
This marijuana news is brought to you by 420 Intel. For the latest breaking cannabis industry news, subscribe to the 420 Intel newsletter. If you'd like to promote your product or service in this area after every article, contact us.
Follow us on Instagram
Connect with us on Linkedin